Fluorescence Lifetime Imaging Microscopy (FLIM) reveals spatial-metabolic changes in 3D breast cancer spheroids.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 03 2023
03 03 2023
Historique:
received:
20
11
2022
accepted:
22
02
2023
entrez:
3
3
2023
pubmed:
4
3
2023
medline:
8
3
2023
Statut:
epublish
Résumé
Cancer cells are mechanically sensitive to physical properties of the microenvironment, which can affect downstream signaling to promote malignancy, in part through the modulation of metabolic pathways. Fluorescence Lifetime Imaging Microscopy (FLIM) can be used to measure the fluorescence lifetime of endogenous fluorophores, such as the metabolic co-factors NAD(P)H and FAD, in live samples. We used multiphoton FLIM to investigate the changes in cellular metabolism of 3D breast spheroids derived from MCF-10A and MD-MB-231 cell lines embedded in collagen with varying densities (1 vs. 4 mg/ml) over time (Day 0 vs. Day 3). MCF-10A spheroids demonstrated spatial gradients, with the cells closest to the spheroid edge exhibiting FLIM changes consistent with a shift towards oxidative phosphorylation (OXPHOS) while the spheroid core had changes consistent with a shift towards glycolysis. The MDA-MB-231 spheroids had a large shift consistent with increased OXPHOS with a more pronounced change at the higher collagen concentration. The MDA-MB-231 spheroids invaded into the collagen gel over time and cells that traveled the farthest had the largest changes consistent with a shift towards OXPHOS. Overall, these results suggest that the cells in contact with the extracellular matrix (ECM) and those that migrated the farthest had changes consistent with a metabolic shift towards OXPHOS. More generally, these results demonstrate the ability of multiphoton FLIM to characterize how spheroids metabolism and spatial metabolic gradients are modified by physical properties of the 3D ECM.
Identifiants
pubmed: 36869092
doi: 10.1038/s41598-023-30403-7
pii: 10.1038/s41598-023-30403-7
pmc: PMC9984376
doi:
Substances chimiques
NAD
0U46U6E8UK
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
3624Informations de copyright
© 2023. The Author(s).
Références
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Acta Biomater. 2021 Sep 1;131:326-340
pubmed: 34246802
Sci Adv. 2018 Mar 07;4(3):eaap9302
pubmed: 29536043
EBioMedicine. 2016 Nov;13:146-156
pubmed: 27743905
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Res. 2014 Jun 1;74(11):3067-75
pubmed: 24686167
Mol Biol Cell. 2016 Sep 1;27(17):2662-74
pubmed: 27385336
Cancer Res. 1990 Sep 15;50(18):6075-86
pubmed: 1975513
Sci Rep. 2019 Nov 20;9(1):17151
pubmed: 31748563
Biophys J. 2009 Aug 19;97(4):1013-21
pubmed: 19686648
IEEE Trans Med Imaging. 2009 Oct;28(10):1585-94
pubmed: 19783496
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7867-7872
pubmed: 30923113
Commun Biol. 2019 Aug 14;2:313
pubmed: 31428701
iScience. 2021 Oct 12;24(11):103252
pubmed: 34755092
Breast Cancer Res. 2008;10(1):201
pubmed: 18226174
Clin Cancer Res. 2018 Jun 1;24(11):2482-2490
pubmed: 29420223
Cancer Res. 2014 Sep 15;74(18):5184-94
pubmed: 25100563
Nat Commun. 2018 Jul 27;9(1):2961
pubmed: 30054475
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Nat Methods. 2005 Dec;2(12):932-40
pubmed: 16299478
Annu Rev Biomed Eng. 2012;14:351-67
pubmed: 22607264
Sci Rep. 2018 Jan 8;8(1):79
pubmed: 29311591
Cancer Res. 2013 Oct 15;73(20):6164-74
pubmed: 24130112
Cell Metab. 2011 Oct 5;14(4):545-54
pubmed: 21982714
Science. 2020 Apr 10;368(6487):
pubmed: 32273439
IEEE Trans Image Process. 2001;10(2):266-77
pubmed: 18249617
J Biomed Opt. 2016 Jun 1;21(6):60503
pubmed: 27300321
Sci Rep. 2020 Oct 27;10(1):18302
pubmed: 33110128
Nature. 2020 Feb;578(7796):621-626
pubmed: 32051585
Cell Metab. 2018 Aug 7;28(2):196-206
pubmed: 30089241
J Biophotonics. 2019 Jun;12(6):e201800379
pubmed: 30706695
Cancer Res. 2005 Oct 1;65(19):8766-73
pubmed: 16204046
Sci Rep. 2013 Dec 05;3:3432
pubmed: 24305550
Nat Cell Biol. 2020 Mar;22(3):310-320
pubmed: 32144411
Cancer Cell Int. 2009 Mar 16;9:7
pubmed: 19291318
Nat Mater. 2014 Oct;13(10):970-8
pubmed: 24930031
Nat Commun. 2020 Oct 9;11(1):5120
pubmed: 33037194
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
Mol Genet Metab. 2010 Aug;100(4):372-8
pubmed: 20483646
Commun Biol. 2021 Mar 19;4(1):371
pubmed: 33742081
Adv Drug Deliv Rev. 2016 Feb 1;97:41-55
pubmed: 26743193
Cell Metab. 2021 Jul 6;33(7):1307-1321
pubmed: 33915111
Nat Cell Biol. 2014 Oct;16(10):992-1003, 1-15
pubmed: 25241037
In Vitro. 1978 Nov;14(11):911-5
pubmed: 730202
Front Psychol. 2019 May 21;10:1089
pubmed: 31231264
Sci Rep. 2018 Nov 20;8(1):17094
pubmed: 30459440
J Biomed Opt. 2020 May;25(7):1-43
pubmed: 32406215
Mol Biol Cell. 2018 Jan 1;29(1):1-9
pubmed: 29118073